Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Does Cannabis Affect Upper Airway Muscle Tone in Sleep Apnoea? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Upper airway collapse is a key contributor to sleep apnoea , leading to disrupted breathing and reduced oxygen levels. Researchers are investigating whether cannabis for upper airway tone can influence muscle stability and improve airflow during sleep. 

Am I eligible for medical cannabis for pain relief?

Airway Muscle Modulation 

Studies indicate that cannabis for upper airway tone may affect neuromuscular activity, potentially enhancing the pharyngeal muscle with cannabinoids and supporting airway patency throughout the night. 

Mechanism of Action 

Cannabis for upper airway tone may act on central and peripheral pathways that regulate airway muscle tone, helping maintain pharyngeal stability and reducing episodes of obstruction. 

Potential Benefits 

By improving pharyngeal muscle with cannabinoids, patients could experience fewer apnoeic events, better sleep quality, and improved oxygenation, which may decrease daytime fatigue and cardiovascular strain. 

Research Considerations 

While early data are promising, further studies are needed to establish which cannabinoids, dosages, and administration methods are most effective for cannabis for upper airway tone without causing adverse effects. 

Evidence suggests cannabis for upper airway tone may enhance airway muscle tone during sleep, potentially benefiting individuals with sleep apnoea. Controlled trials are essential to confirm these effects and determine safe, clinically useful applications. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea . 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories